BIOMAT Database Logo BIOMAT Database Logo

Gas chromatographic analysis of sodium di-n-propylacetate in human plasma. 1978

J C Libeer, and S Scharpé, and P Schepens, and R Verkerk

UI MeSH Term Description Entries
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012997 Solvents Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant & Hackh's Chemical Dictionary, 5th ed) Solvent
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid

Related Publications

J C Libeer, and S Scharpé, and P Schepens, and R Verkerk
Gas chromatographic determination of sodium di-n-propylacetate levels in the plasma and urine.
March 1980, Il Farmaco; edizione pratica,
J C Libeer, and S Scharpé, and P Schepens, and R Verkerk
A rapid and sensitive gas-liquid chromatographic procedure for the micro determination of sodium valproate (sodium di-N-propylacetate) in plasma or serum.
December 1977, Clinica chimica acta; international journal of clinical chemistry,
J C Libeer, and S Scharpé, and P Schepens, and R Verkerk
[Clinical--pharmacological aspects of treatment with sodium di-n-propylacetate].
May 1977, Ugeskrift for laeger,
J C Libeer, and S Scharpé, and P Schepens, and R Verkerk
Progressive myoclonic epilepsy. The response to sodium di -- n -- propylacetate.
January 1974, Proceedings of the Australian Association of Neurologists,
J C Libeer, and S Scharpé, and P Schepens, and R Verkerk
[Deprakine. Sodium di-n-propylacetate, orfiril--a new antiepileptic agent].
April 1979, Ugeskrift for laeger,
J C Libeer, and S Scharpé, and P Schepens, and R Verkerk
Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review.
November 1975, Epilepsia,
J C Libeer, and S Scharpé, and P Schepens, and R Verkerk
Pharmacokinetics of di-n-propylacetate in epileptic patients.
February 1975, European journal of clinical pharmacology,
J C Libeer, and S Scharpé, and P Schepens, and R Verkerk
[Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study].
May 1977, Ugeskrift for laeger,
J C Libeer, and S Scharpé, and P Schepens, and R Verkerk
[Sodium di-n-propylacetate: evaluation of its so-called psychotropic effect. A controlled study].
May 1977, Ugeskrift for laeger,
J C Libeer, and S Scharpé, and P Schepens, and R Verkerk
Gas chromatographic analysis of phenylethylmalonamide in human plasma.
May 1987, Journal of chromatography,
Copied contents to your clipboard!